|
| |
| | | 67345 | | 15.08.2019 | | Mepha Pharma AG | | | | | | | 14.08.2024 | | Behandlung der hyperaktiven Harnblase | | | | | | | | 05.02. | | |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Desfesoterodin-Mepha retard 3.5 mg | Depotabs | Retard-Tabletten (Desfesoterodini Succinas 3.5 mg) | G04BD13 | | | 02 | Desfesoterodin-Mepha retard 7 mg | Depotabs | Retard-Tabletten (Desfesoterodini Succinas 7 mg) | G04BD13 | |
|
|
|
